Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin treatment in systemic lupus erythematosus patients
ISRCTN51612701Phase 4Completed
- Sponsor
- Polish Ministry of Science and Higher Education
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in systemic lupus erythematosus (SLE) (2 arms), sponsored by Polish Ministry of Science and Higher Education. Primary endpoints: Calcium deposits in coronary arteries and Number of myocardial left ventricle segments with perfusion defects. Started Jan 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ISRCTN51612701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51612701.